Anzeige
Mehr »
Login
Mittwoch, 26.08.2020 Börsentäglich über 12.000 News von 650 internationalen Medien
Alle ausgestochen und neuen SILBER-DISTRIKT erworben! Nächste Raketen-Stufe zündet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investor's Business Daily

  • 24 h
  • letzte 200 News
Zeit Aktuelle Nachrichten
Di Salesforce Earnings Top Estimates, Revenue Guidance Above Views; Stock Jumps
Di Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
Di Design Software Firm Autodesk Beats Second-Quarter Estimates
Di Is Raytheon Stock A Buy Right Now As Elite Status Fades?
Di Hillenbrand Surges On Double-Digit Profit Growth Amid Acquisitions
Di Facebook Stock Hits High As It Announces New E-Commerce Features
Di Mosaic Strength Grows Organically, Pushing Its Stock Into Elite Group
Di IBD Rating Upgrades: ELF Beauty Shows Improved Relative Price Strength
Di Stocks To Watch With Earnings Due: Dollar General
Di Top-Rated Stocks: TRI Pointe Sees Composite Rating Climb To 96
Di Lennar Joins Rank Of Stocks With 95-Plus Composite Rating
Di Westlake Chemical Shows Improved Relative Price Performance; Still Shy Of Benchmark
Di Here's How Many Jobs American Air Might Cut Without Aid Extension
Di Car Parts Retailer LKQ Sees Rising Relative Strength Rating
Di Stock Upgrades: Estee Lauder Shows Rising Relative Strength
Di Energy Stocks And Industry News: Oil, Gas, Solar, Coal
Di Luxury Homebuilder To Report As Sales, Construction Boom
Di Chip Stocks To Watch And Semiconductor Industry News
Di Xpeng IPO Looms As China Electric Car Stocks Act Bullishly
Di 'Tesla Of China' Breaks Out Into Buy Zone As Rival Eyes IPO Entry
Di Ryanair Shows Rising Price Performance With Jump To 81 RS Rating
Di Stocks Showing Market Leadership: Revance Therapeutics Earns 93 RS Rating
Di AstraZeneca Coronavirus Treatment Testing Begins; 'Important Milestone'
Di Best Buy Smashes Second-Quarter Targets As Consumers Shelter In Place
Di Medical Device Giant Rises On Earnings Beat